Surgical management of hepatic hemangioma in Sudanese patients: A single-center prospective study

Purpose: Hepatic hemangioma (HH) is the most frequent hepatic benign lesion that identified by chance during radiological imaging. Asymptomatic patients do not require surgical treatment unless HH size is greater than 5 cm. Few studies in the literature supported surgical intervention. The purpose of this study is to reflect surgical outcomes of appropriate therapeutic technique for HH in order to obtain outstanding results. Methods: This is a prospective hospital-based study for one hundred and seven patients diagnosed with HH who had elective surgical procedures performed between February 2021 and January 2023. Results: Females were more likely to develop hepatic hemangioma (65.4%), with a 2:1 ratio. The age distribution of patients was 31 to 45 years, accounting for (62.6%) of the total. The use of oral contraceptive pills was the most commonly reported comorbidity in (57%) of patients. Incidental HH was identified in (44.8%) of asymptomatic patients. Enhanced contrast abdominopelvic CT-scans revealed a single HH lesion in (74.8%) of patients. Hepatic enucleation underwent for progressive HH size expansion (> 10 cm) with a surgery time of 3–4 hours in (37.38%) of patients. Postoperative complications were discovered in (9.34%) of patients. Of these, (2.8%) developed minor wound infections. Cavernous HH is the most prevalent histopathologic subtype revealed in (41.14%) of patients. The mortality rate was zero. Conclusions: To get appropriate surgical outcomes particularly in the developing countries, clinicians must pursue the right treatment choices. Therefore, surgical intervention for hepatic hemangioma recommended as a highly effective curative approach that associated with minimal morbidities.